Description
CJC-1295 with DAC is a synthetic modified peptide compound engineered for laboratory research. The molecule features a Drug Affinity Complex (DAC) modification that enhances its stability in experimental conditions. Laboratory research demonstrates specific molecular pathway interactions and distinct binding properties in controlled models. The compound is designed with a 30-amino acid sequence structure, showing selective receptor affinity in vitro studies. The DAC modification allows for extended stability in solution compared to the non-modified variant, making it particularly suitable for prolonged laboratory studies.
Drago Pharma Properties
| Chemical Formula | C152H252N44O42 |
| Synonyms | CJC1295 Without DAC, CJC1295 With DAC, 446262-90-4 |
| Molar Mass | 3367.9 g/mol |
| CAS Number | 446262-90-4 |
| PubChem | 91976842 |
| Total Amount of the Active Ingredient | 2mg per vial |
| Shelf Life | 36 months |
Drago Pharma Important Notice
FDA Disclaimer: The statements made within this website have not been evaluated by the US Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure or prevent any disease. All products are for laboratory developmental research USE ONLY. Products are not for human consumption.
Note: These peptides are freeze-dried, a process that not only extends shelf life but also preserves the purity and integrity of the peptides during storage. We do not use any fillers in this process.
There are no reviews yet.